Jacquelyn Tyson-hope, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 301-618-6100 Fax: 410-793-0809 |
Margaret M Rizzutti, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 443-332-4088 Fax: 410-793-0809 |
Lonnie Herring, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 301-618-6100 Fax: 410-793-0809 |
Mrs. Karen Abigail Robertson-sanchez, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 301-618-6100 |
Theresa M Glaser, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 301-618-6100 |
Miguel Sanchez, DNP Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 301-618-2000 |
Rhoda Joan Walter, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 443-332-4088 Fax: 410-793-0809 |
Mr. Jamie Chen, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 410-793-0791 Fax: 410-793-0809 |
Dr. Alexa Kleiman, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 301-618-2000 |
Dr. Mariyam Ibironke Popoola, DNP, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 301-618-6100 |
News Archive
Health inequality in Europe is resulting in huge social and economic costs to the region, and progress towards reducing health inequalities should be one of the main criteria by which the effectiveness of health systems and governments as a whole are assessed, according to a Review published in The Lancet.
Genentech, Inc., a wholly owned member of the Roche Group, today announced positive results from a Phase II study of trastuzumab-DM1 (T-DM1). As assessed by independent review, T-DM1 shrank the tumors (also known as objective response) in 33 percent of women with advanced (metastatic) HER2-positive breast cancer that had worsened following previous treatment.
Meperidine, an opioid analgesic commonly used to control shivering in accidental or therapeutic hypothermia, has been linked to increased seizure risk, but a new study finds little published evidence to support this risk.
Because of its high cost, some state Medicaid programs and prison systems are refusing to provide Sovaldi to any but the sickest patients. Most recently, Oregon last month threatened to limit access to the drug unless it can get Sovaldi at a deeply discounted price. But Sovaldi is only the beginning. Expensive new treatments for certain cancers, rheumatoid arthritis and other conditions also have rattled Medicaid officials, patients and health care providers. What can states do to hold down drug costs? Drug pricing is a complicated and opaque process.
The existing prognostic scores for early-risk stroke prediction after transient ischaemic attack (TIA have been validated and refined to develop a unified score that is more predictive than previous methods, according to an Article published in this week's issue of The Lancet.
› Verified 3 days ago